Belgium· BE-AMP-SAM175567-00
NovoSeven 2.4 mg
A coagulation factor viia product containing eptacog alfa (activated), registered in Belgium by Novo Nordisk. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Coagulation factor viia is registered in 11 of 19 countries.
Countries holding a registration under ATC B02BD08 (coagulation factor viia), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Coagulation factor viia · ATC B02BD08
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Eptacog Alfa (Activated)
- Manufacturer
- Novo Nordisk
- Country
- Belgium (BE)
- ATC code
- B02BD08
- ATC class
- Coagulation factor VIIa
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for coagulation factor viia.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Coagulation factor viia · interactions on record
5 records
- 2 severe
- 2 moderate
- 1 minor
Most severe, free to view
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- Faktor VIII-Inhibitor Bypass Aktivität - FEIBAB02BD03moderate
- EmicizumabB02BX06moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Coagulation factor viia in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCevenfacta 1mg (45,000units) powder and solvent for solution for injection vialsLFB Biopharmaceuticals Ltd
- IrelandCEVENFACTA 1 mg (45 KIU) powder and solvent for solution for injectionLaboratoire francais du Fractionnement et des Biotechnolgies
- CzechiaCEVENFACTALaboratoire Français du Fractionnement et des Biotechnologies, Puteaux
- SwedenCEVENFACTA 1 mg Pulver och vätska till injektionsvätska, lösningLaboratoire français du Fractionnement et des Biotechnologies
- FinlandNovosevenNovo Nordisk A/S
- SpainNOVOSEVEN 1 mg (50 KUI) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLENovo Nordisk A/S
- SwitzerlandNovoSeven 1 mg, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungNovo Nordisk Pharma AG
- NetherlandsNovoSeven 1 mg (50 KIE) poeder en oplosmiddel voor oplossing voor injectieNovo Nordisk A.S.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Cevenfacta, Novoseven
- Liechtenstein · Cevenfacta
- Norway · Cevenfacta, Novoseven
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dfff2556-4632-4b43-b7a4-86045e2f704e GET /v1/drugs/dfff2556-4632-4b43-b7a4-86045e2f704e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "NovoSeven 2.4 mg",
"name_fr": "NovoSeven 2.4 mg",
"name_nl": "NovoSeven 2.4 mg",
"amp_code": "SAM175567-00",
"strengths": [
"2.4000"
],
"pack_count": 1,
"substances": [
"Eptacog Alfa (Activated)"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Coagulation Factor VIIa",
"authorisation_numbers": [
"EU/1/96/006/002"
]
}See everything about coagulation factor viia.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.